Shopping Cart
Remove All
Your shopping cart is currently empty
Gimsilumab (MORAb-022) is a humanized monoclonal antibody targeting granulocyte macrophage colony-stimulating factor for the study of COVID-19-induced inflammation and hypoxemia.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $169 | In Stock | In Stock | |
| 5 mg | $423 | In Stock | In Stock | |
| 10 mg | $623 | - | In Stock | |
| 25 mg | $997 | - | In Stock |
| Description | Gimsilumab (MORAb-022) is a humanized monoclonal antibody targeting granulocyte macrophage colony-stimulating factor for the study of COVID-19-induced inflammation and hypoxemia. |
| Synonyms | MORAb-022, KIN-1901 |
| Reactivity | Human |
| Verified Activity | Immobilized huGM-CSF-Nhis at 2 μg/mL (30 μL/well) can bind Gimsilumab, with the EC50 is 0.008434 μg/mL. |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Molecular Weight | 145.8 kDa |
| Cas No. | 1648796-29-5 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | IgG1 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.